Hemostatic Disorders: all 514 studies
Page 2 of 6. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.
- A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia ACompletedNCT01731600Phase 3Results posted
- Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and CoagulopathyCompletedNCT01598831Phase 3Results posted
- Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in TraumaCompletedNCT01536496Not applicableResults posted
- Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia ACompletedNCT01493778Phase 3Results posted
- Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.CompletedNCT01489111Phase 3Results posted
- Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia ACompletedNCT01480180Phase 3Results posted
- The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary BypassCompletedNCT01435304Not applicableResults posted
- Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773CompletedNCT01395810Phase 3Results posted
- Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsCompletedNCT01392547Phase 3Results posted
- Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCompletedNCT01386528Phase 3Results posted
- Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B PatientsCompletedNCT01333111Phase 3Results posted
- Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit DeficiencyCompletedNCT01253811Phase 3Results posted
- Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit DeficiencyCompletedNCT01230021Phase 3Results posted
- Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia ACompletedNCT01138501Phase 3Results posted
- Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia ACompletedNCT01029340Phase 3Results posted
- Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015CompletedNCT00984126Phase 3Results posted
- Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725CompletedNCT00978380Phase 3Results posted
- Clinical and Economic Implications of Genetic Testing for Warfarin ManagementCompletedNCT00964353Phase 4Results posted
- Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart SurgeryCompletedNCT00914589Phase 2Results posted
- PROPACT: Retrospective Prophylaxis Patient Case CollectionCompletedNCT00882778Results posted
- A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,CompletedNCT00868309Phase 2Results posted
- Safety and Efficacy of Turoctocog Alfa in Haemophilia A SubjectsCompletedNCT00840086Phase 3Results posted
- Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy VolunteersCompletedNCT00822185Phase 1Results posted
- An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical ProcedureCompletedNCT00803101Phase 3Results posted
- Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited DeficiencyCompletedNCT00713648Phase 3Results posted
- Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant TherapyCompletedNCT00708435Phase 3Results posted
- Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT00703911Results posted
- BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)CompletedNCT00586521Phase 4Results posted
- Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsTerminatedNCT00555555Phase 4Results posted
- Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2Results posted
- Safety, Pharmacokinetics and Efficacy of an ATIII ConcentrateTerminatedNCT00319228Phase 2/3Results posted
- Evaluation of Recombinant Factor VIIa in Patients With Severe BleedingTerminatedNCT00184548Phase 3Results posted
- Innovative Approaches to Identify Causative Genetic Variants in Patients With Unexplained Bleeding DisordersCompletedNCT07870057
- Association Between Hypomagnesemia and Coagulopathy in SepsisCompletedNCT07576621
- The Bleeding Assessment Tool (BAT)Active, not recruitingNCT07560007
- Hot Climate on Bleeding Tendency After Cardiac Surgery in Egyptian PatientsCompletedNCT07510022
- Effects of Lipid Emulsions on CoagulationCompletedNCT07470385
- Microcirculation and Coagulopathy in SepsisCompletedNCT07404475
- The Incidence of Early Trauma Induced Coagulopathy and Hyperfibrinolysis in Severely Injured Trauma Patients in the Emergency Room: a Retrospective Cohort StudyCompletedNCT07186712
- A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.CompletedNCT07176728Phase 1
- Assessment of Artificial Intelligence Algorithms for ROTEMWithdrawnNCT07043556
- Thrombelastography for Coagulopathy in Chinese SnakebitesCompletedNCT06860503
- Comparison Between Colloids and Crystalloids on Coagulation and Blood LossCompletedNCT06683079
- Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and ObstetricsCompletedNCT06635564
- Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic IndexesTerminatedNCT06630572Phase 4
- Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of HeparinCompletedNCT06517563Phase 1
- Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral AnticoagulantCompletedNCT06372483Phase 1
- Quantra Point-of-Care Hemostasis MonitoringActive, not recruitingNCT06328647Not applicable
- Comparison of the Effect of Warfarin and Direct Oral AnticoagulantsCompletedNCT06269302
- Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological CoagulopathyCompletedNCT06230640
- BVA-200 vs BVA-100 Validation StudyCompletedNCT06227819
- Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia AActive, not recruitingNCT06224907Phase 3
- The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated HeparinCompletedNCT06174961Phase 4
- Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.CompletedNCT06154018Not applicable
- Bariatric Surgery on obesity-and Diabetes-associated Abnormalities of Hemostasis, Inflammation and Vascular Function.CompletedNCT06071559Not applicable
- Protection of Knee Joints in Bleeding Disorder PatientsCompletedNCT06039904Not applicable
- Quantra QStat Sample Type ComparisonCompletedNCT06025708
- Study of TU7710 in Warfarin Anti-coagulated Healthy Male SubjectsCompletedNCT06025552Phase 1
- Subclinical Impairment of Cardiovascular System in Patients With PsoriasisCompletedNCT05957120
- Caudal Block & Hip Fracture Surgery in Anticoagulated PatientCompletedNCT05946863
- Blood Coagulation Profile After Liver Resection.CompletedNCT05824013
- Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.WithdrawnNCT05790109Not applicable
- Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day WorkersActive, not recruitingNCT05775731
- Prevention of Cefoperazone-induced CoagulopathyCompletedNCT05742295Phase 4
- Ascending Dose Study of FrontlineODP™ Spray Dried PlasmaCompletedNCT05629338Phase 1
- Nadroparin Pharmacokinetics in Different Stages of COVID-19CompletedNCT05621915
- Safety of Anticoagulant Therapy After Tissue Glue for Gastric VaricesStatus unknownNCT05545475
- Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam SodiumCompletedNCT05535309
- Effect of Hypocalcemia on the Outcome of Elderly Major Trauma Patients With Trauma-induced CoagulopathyStatus unknownNCT05530161
- Coagulation Disturbances in COVID-19 Septic PatientsCompletedNCT05496816
- Coagulation in Acute Aortic DissectionCompletedNCT05484830Not applicable
- Fibrinogen Early In Severe Trauma StudY IICompletedNCT05449834Phase 3
- Effect of Prophylactic Fibrinogen Concentrate In Scoliosis SurgeryCompletedNCT05391412Phase 4
- Coagulation and Fibrinolysis of Estradiol in TranswomenTerminatedNCT05387577Early Phase 1
- Rare Inherited Bleedig Disorders in Children at Sohag University HospitalStatus unknownNCT05381922
- Quantra® System With the QStat® Cartridge in TraumaTerminatedNCT05376462
- The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
- Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation StudyCompletedNCT05295693
- Quantra QPlus Sample Type ComparisonCompletedNCT05290675
- The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy VolunteersCompletedNCT05272475Not applicable
- The Influence of Tramadol on Platelet FunctionCompletedNCT05237492Phase 4
- Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMOCompletedNCT05226442Phase 2/3
- Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.CompletedNCT05224388
- Screening for Bleeding Disorders in ChildrenCompletedNCT05214300
- Inflammatory Bowel Disease and Thromboembolic EventsCompletedNCT05162339
- Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older SubjectsCompletedNCT05152420Phase 1
- Coagulopathy in Acute Aortic SyndromeStatus unknownNCT05149261
- Impact of Balanced Crystalloid and Colloid Infusion on Haemostasis in Healthy Male VolunteersStatus unknownNCT05148650Not applicable
- Hemostasis Assesment After Application of Lyophilisate Collagen in Nail SurgeryStatus unknownNCT05140161Not applicable
- The Glycocalyx in COVID-19 Patients. A Pilot StudyCompletedNCT05137249
- Hemostatic Profiles in Pediatric CKDCompletedNCT05064267
- Bleeding Oral Anticoagulant Analyzer (BOA)CompletedNCT05026281Not applicable
- A Comparison of General Versus Peripheral Nerve Block for Lower Extremity Amputation in Diabetic Patients With Bleeding Tendency: a Retrospective StudyStatus unknownNCT05012059
- Effect of Chamomile Intake on Blood Coagulation Tests in Healthy VolunteersCompletedNCT05006378Not applicable
- Mitochondrial Dysfunction in Trauma-related CoagulopathyStatus unknownNCT05004844
- Systematic Analysis of a Standardized Questionnaire to Detect Possible Bleeding Disorders and Its Impact on Perioperative Hemostasis ManagementCompletedNCT04993170
- Incidence and Predictors of Bleeding Diathesis Development Due to DIC in Cirrhosis and ACLF Patients Undergoing CRRTStatus unknownNCT04960163
- Extracorporeal Life Support and Modification of HemostasisCompletedNCT04912336
- Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel DiseaseStatus unknownNCT04896203
- Clotting Parameters After Medical AbortionCompletedNCT04824118